Stay Updated with the Latest Novo Nordisk A/S NVO News in Real Time
Find NVO news now at Meyka AI. Stay informed with the latest Novo Nordisk A/S stocks updates, including price news, market analysis, and expert insights.
Amazon Pharmacy Expands $50/Month GLP-1 Access for Medicare Patients, Targets 4,500 US Cities by 2026
Amazon Pharmacy announced Thursday, August 6, 2026, that it joined the federal Medicare GLP-1 Bridge Program. Eligible Medicare Part D patients can now access GLP-1 medications for a flat $50 monthly copay. The program covers Wegovy, Zepbound, and Foundayo, with free home delivery included. Amazon Pharmacy currently serves over 3,100 US cities, expanding toward 4,500…
TGA Warns GLP-1 Drugs Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic and Mounjaro linked to 36 cases of NAION, a rare eye disorder causing permanent blindness. No treatment available.
TGA Warns GLP-1 Drugs Like Ozempic Linked to Rare Eye Blindness July 25
Australia’s TGA warns GLP-1 drugs like Ozempic may cause NAION, a rare eye disorder leading to blindness. 36 cases reported. No treatment available. Patients urged to seek urgent medical attention if vision changes occur.
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.
Novo Nordisk (NYSE: NVO) Sues Eli Lilly (NYSE: LLY) Over Allegedly Misleading GLP-1 Drug Advertising
On 21 July 2026, Novo Nordisk (NYSE: NVO) filed a lawsuit against Eli Lilly (NYSE: LLY), accusing its rival of misleading consumers through advertising that compares their blockbuster GLP-1 weight-loss drugs. The legal dispute comes as demand for obesity treatments keeps rising and competition between the two drugmakers becomes more intense. The outcome could affect…
Warren Buffett’s 2034 Donation Plan Could Leave Berkshire Hathaway Stock 22% Undervalued
On July 14, 2026, Warren Buffett announced that he intends to donate all of his remaining Berkshire Hathaway shares by December 31, 2034. The decision extends one of the largest charitable commitments ever made by an individual. It has also renewed interest in Berkshire Hathaway’s valuation and whether the stock is trading below its estimated…
European Stocks Edge Higher Despite Cancellation of U.S. Iran Talks; STOXX 600 Gains 0.2%
European stocks traded slightly higher on Friday despite the cancellation of planned United States and Iran peace talks. Investors remained cautious but did not rush to sell equities. Instead, they focused on stronger energy shares, stable healthcare stocks, and encouraging inflation data from Germany. The pan-European STOXX 600 index added 0.2%, showing that markets remained…
Queen Mary of Denmark Leads Summer Cruise Through Danish Cities, June 04
Queen Mary and King Frederik X conduct annual summer cruise June 1-4, 2026, visiting Danish cities including Grenaa with school and town hall tours.
Eli Lilly And Co Hits $1,065 as UBS Highlights 28% Weight Loss Results From Retatrutide Study
Eli Lilly and Company has reached a major milestone as its stock price climbed to $1,065.00, driven by renewed investor optimism following strong clinical trial results for its experimental obesity drug Retatrutide. The surge reflects growing confidence in the company’s long-term growth pipeline and its leadership in the global weight-loss drug market. The latest update…